Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males
Specially designed microsite (www.meettheburns.com) targets first time athlete’s foot sufferers and parents.
To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/tinactin/38431/
Athlete’s foot is an infection caused by direct contact with fungus. People are most susceptible when their feet are sweating or when wearing shoes that lack proper ventilation. The condition is commonly picked up by walking barefoot in locker rooms, pools and other public areas.
TINACTIN CHILL is targeted to address the needs of the first time athlete’s foot sufferer, which are primarily young males ages 14 to 22. “Research shows that experiencing athlete’s foot for the first time can be very frightening and intimidating for young men,” said
To reach this audience, Schering-Plough developed an innovative Web site, www.meettheburns.com. The site features a series of “Webisodes” highlighting the fictitious Burns family and a character named “Gus” representing fungus. Each segment presents an athlete’s foot treatment message in a situation comedy style that is entertaining and identifies well with teens. “Many young men are reluctant to talk about their situation when they first experience athlete’s foot,” O’Mullane said. “However, they often seek information on the Internet. By developing this Web site, we can reach young men and help inform them and their parents that there are effective and easy to use treatments for this common condition.”
About TINACTIN CHILL
TINACTIN CHILL is clinically proven to cure most athlete’s foot and can even help prevent athlete’s foot with daily use. The Liquid Spray contains ingredients that provide an extra cooling sensation and the Deodorant Powder Spray will fight odor all day long in addition to treating athlete’s foot.
TINACTIN CHILL is available at most mass retailers, drugstores, grocery stores and online outlets.
Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough, an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough’s vision is to “Earn Trust, Every Day” with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in
SOURCE Schering-Plough Corporation